← FDA Drug Approvals (Drugs@FDA)

TALZENNA

NDA · New Drug Application · Sponsor: PFIZER · Approved 2024-03-07

Drug application

FDA Application #

NDA217439

Application type

New Drug Application

Brand name

TALZENNA

Generic name

TALAZOPARIB

Active ingredients

TALAZOPARIB TOSYLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

PFIZER

Manufacturer

U.S. Pharmaceuticals

First approval

2024-03-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown